Podcasts

Why do we need to continue innovating in the CGT industry?

Invent Life Sciences #S3E1

The Cell and Gene Therapy (CGT) industry has made remarkable strides, with significant advancements and the approval of groundbreaking technologies in recent years. However, have we become too dependent on older methods, and are we doing enough to ensure these new therapies are reaching as many patients as possible?

In this episode, we tackle these questions while exploring one fundamental issue: Why? Why is it essential to continue innovating to broaden patient access, develop new therapies, and push the industry forward?

Guests:

  • Tay Salimullah, Chief Access Commercial Officer at Novartis
  • Jason Jones, Global Business Development Lead at Cellular Origins

Talk to us about your next project

Get in touch

Talk to us about your next project

Whether you would like to discuss a project or would like to learn more about our work, get in touch through the form below.

Last Updated
September 24, 2024

You might also like

Insights
Room temperature stable mRNA therapeutics: a breakthrough for global access
Drug delivery solutions
Bioprocessing
Cell and gene therapy tools
Podcasts
How innovation can broaden access and propel the CGT industry forward?
Cell and gene therapy tools
Bioprocessing
Podcasts
Invent Life Sciences from TTP - Season 3 Trailer
Cell and gene therapy tools
Bioprocessing
Cell and gene therapy tools
Bioprocessing

Get the latest from TTP

Join our community to get the latest news and updates on our work at TTP.

You will occasionally receive expert insights from across our areas of focus and hear directly from our engineers and scientists on the newest developments in the field.

Subscribe

Get the latest from TTP

Join our community to get the latest news and updates on our work at TTP.

Want to work 
at TTP?

Find open positions and contact us to learn more.

Find out more

Overlay title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Text Link
Text Link
No items found.